Retatrutide 40mg/3ml Injectable Pen (Triple-Agonist GLP-1/GIP/GCGR) — Health Arcadi

Description

Retatrutide 40mg/3ml Injectable Pen (Triple-Agonist GLP-1/GIP/GCGR) — Health Arcadi

Retatrutide is a next-generation triple-receptor agonist engineered to interact with GLP-1, GIP, and glucagon receptors. This advanced formulation has attracted significant attention for its potential role in supporting metabolic efficiency, appetite control, and body composition management.

Manufactured by Health Arcadi, this product is supplied as a ready-to-use prefilled injection pen containing 40mg of active compound in a 3ml solution, ensuring accurate dosing and convenient administration.

🔬 Key Features

✔ Triple-agonist activity (GLP-1 / GIP / GCGR)
✔ Supports appetite regulation mechanisms
✔ Promotes metabolic function and energy balance
✔ Designed for body composition support
✔ Long-acting formulation
✔ Prefilled pen for convenience and dosing accuracy
✔ Pharmaceutical-grade manufacturing standards

⚡ Potential Benefits

Retatrutide 40mg/3ml Injectable Pen (Triple-Agonist GLP-1/GIP/GCGR) — Health Arcadi

• Support for appetite control

• Assistance with metabolic regulation

• Body fat management support

• Reduced food cravings

• Support for stable energy levels

• Potential improvement in glucose metabolism

💉 Product Specifications

Brand: Health Arcadi
Active Compound: Retatrutide
Total Content: 40mg
Volume: 3ml
Form: Prefilled Injectable Pen
Administration Route: Subcutaneous injection
Formulation: Long-acting solution

📦 Package Contents

• 1 × Retatrutide Prefilled Pen (40mg/3ml)

• Sealed protective packaging

🧊 Storage Instructions

• Store refrigerated at 2–8°C

• Do not freeze

• Protect from direct light

• Keep in original packaging until use

⚠️ Important Information

• Intended for research or professional use only

• Not intended to diagnose, treat, cure, or prevent any disease

• Use only under guidance of a qualified professional

• Keep out of reach of children

Retatrutide 40mg/3ml Injectable Pen (Triple-Agonist GLP-1/GIP/GCGR) — Health Arcadi